111 related articles for article (PubMed ID: 1932571)
21. Design, synthesis, and biological activities of cyclic lactam peptide analogues of dynorphine A(1-11)-NH2.
Lung FD; Collins N; Stropova D; Davis P; Yamamura HI; Porreca F; Hruby VJ
J Med Chem; 1996 Mar; 39(5):1136-41. PubMed ID: 8676350
[TBL] [Abstract][Full Text] [Related]
22. Highly potent side chain-main chain cyclized dermorphin-deltorphin analogues: an integrated approach including synthesis, bioassays, NMR spectroscopy and molecular modelling.
Ro S; Zhu Q; Lee CW; Goodman M; Darlak K; Spatola AF; Chung NN; Schiller PW; Malmberg AB; Yaksh TL
J Pept Sci; 1995; 1(3):157-74. PubMed ID: 9222993
[TBL] [Abstract][Full Text] [Related]
23. Conformational analysis of an opioid peptide in solvent media that mimic cytoplasm viscosity.
Temussi PA; Picone D; Saviano G; Amodeo P; Motta A; Tancredi T; Salvadori S; Tomatis R
Biopolymers; 1992 Apr; 32(4):367-72. PubMed ID: 1623132
[TBL] [Abstract][Full Text] [Related]
24. Stereospecificity of amino acid side chains in deltorphin defines binding to opioid receptors.
Lazarus LH; Salvadori S; Balboni G; Tomatis R; Wilson WE
J Med Chem; 1992 Apr; 35(7):1222-7. PubMed ID: 1313878
[TBL] [Abstract][Full Text] [Related]
25. 14-membered cyclic opioids related to dermorphin and their partially retro-inverso modified analogues. II. Preferred conformations in solution as studied by 1H-NMR spectroscopy.
Yamazaki T; Mierke DF; Said-Nejad OE; Felder ER; Goodman M
Int J Pept Protein Res; 1992 Feb; 39(2):161-81. PubMed ID: 1517015
[TBL] [Abstract][Full Text] [Related]
26. Post-translational amino acid racemization in the frog skin peptide deltorphin I in the secretion granules of cutaneous serous glands.
Auvynet C; Seddiki N; Dunia I; Nicolas P; Amiche M; Lacombe C
Eur J Cell Biol; 2006 Jan; 85(1):25-34. PubMed ID: 16373172
[TBL] [Abstract][Full Text] [Related]
27. pKa and volume of residue one influence delta/mu opioid binding: QSAR analysis of tyrosine replacement in a nonselective deltorphin analogue.
Heyl DL; Schullery SE; Renganathan K; Jayamaha MN; Rodgers DW; Traynor JR
Bioorg Med Chem; 2003 Aug; 11(17):3761-8. PubMed ID: 12901921
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and receptor binding analysis of dermorphin hepta-, hexa- and pentapeptide analogues. Evidence for one- and two-side binding models for the mu-opioid receptor.
Attila M; Salvadori S; Balboni G; Bryant SD; Lazarus LH
Int J Pept Protein Res; 1993 Dec; 42(6):550-9. PubMed ID: 7905867
[TBL] [Abstract][Full Text] [Related]
29. Interaction of deltorphin with opioid receptors: molecular determinants for affinity and selectivity.
Lazarus LH; Salvadori S; Attila M; Grieco P; Bundy DM; Wilson WE; Tomatis R
Peptides; 1993; 14(1):21-8. PubMed ID: 8382810
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and receptor binding of opioid peptide analogues containing beta3-homo-amino acids.
Wilczyńska D; Kosson P; Kwasiborska M; Ejchart A; Olma A
J Pept Sci; 2009 Nov; 15(11):777-82. PubMed ID: 19787815
[TBL] [Abstract][Full Text] [Related]
31. A conformational comparison of two stereoisomeric cyclic dermorphin analogues employing NMR and computer simulations.
Mierke DF; Schiller PW; Goodman M
Biopolymers; 1990; 29(6-7):943-52. PubMed ID: 2369622
[TBL] [Abstract][Full Text] [Related]
32. Function of negative charge in the "address domain" of deltorphins.
Lazarus LH; Salvadori S; Santagada V; Tomatis R; Wilson WE
J Med Chem; 1991 Apr; 34(4):1350-5. PubMed ID: 1849997
[TBL] [Abstract][Full Text] [Related]
33. Opioid peptides. Synthesis and binding properties of dermorphin related heptapeptides.
Salvadori S; Marastoni M; Balboni G; Borea P; Tomatis R
Int J Pept Protein Res; 1989 Feb; 33(2):94-102. PubMed ID: 2540104
[TBL] [Abstract][Full Text] [Related]
34. Conformation of deltorphin-II in membrane environment studied by two-dimensional NMR spectroscopy and molecular dynamics calculations.
Ohno Y; Segawa M; Ohishi H; Doi M; Kitamura K; Ishida T; Inoue M; Iwashita T
Eur J Biochem; 1993 Feb; 212(1):185-91. PubMed ID: 8383038
[TBL] [Abstract][Full Text] [Related]
35. Conformational restriction of Tyr and Phe side chains in opioid peptides: information about preferred and bioactive side-chain topology.
Tourwé D; Verschueren K; Frycia A; Davis P; Porreca F; Hruby VJ; Toth G; Jaspers H; Verheyden P; Van Binst G
Biopolymers; 1996 Jan; 38(1):1-12. PubMed ID: 8679939
[TBL] [Abstract][Full Text] [Related]
36. Topochemical design of bioactive peptides and peptidomimetics.
Goodman M; Ro S; Yamazaki T; Spencer JR; Toy A; Huang Z; He Y; Reisine T
Bioorg Khim; 1992; 18(10-11):1375-93. PubMed ID: 1363715
[TBL] [Abstract][Full Text] [Related]
37. Conversion of enkephalin and dermorphin into delta-selective opioid antagonists by single-residue substitution.
Tancredi T; Salvadori S; Amodeo P; Picone D; Lazarus LH; Bryant SD; Guerrini R; Marzola G; Temussi PA
Eur J Biochem; 1994 Aug; 224(1):241-7. PubMed ID: 8076645
[TBL] [Abstract][Full Text] [Related]
38. cDNAs encoding [D-Ala2]deltorphin precursors from skin of Phyllomedusa bicolor also contain genetic information for three dermorphin-related opioid peptides.
Richter K; Egger R; Negri L; Corsi R; Severini C; Kreil G
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4836-9. PubMed ID: 2352951
[TBL] [Abstract][Full Text] [Related]
39. Synthesis, Biological Activity, and NMR-Based Structural Studies of Deltorphin I Analogs Modified in Message Domain with a New α,α-Disubstituted Glycines.
Lasota A; Frączak O; Muchowska A; Nowakowski M; Maciejczyk M; Ejchart A; Olma A
Chem Biol Drug Des; 2016 Jun; 87(6):824-32. PubMed ID: 26808639
[TBL] [Abstract][Full Text] [Related]
40. Molecular modeling study of the opioid receptor interactions with series of cyclic deltorphin analogues.
Slusarz MJ
J Pept Sci; 2011 Aug; 17(8):554-64. PubMed ID: 21538712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
